Clinical Trials
All Clinical Trials - Page 14 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05625087Phase 2Active Not Recruiting
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib
Gonadorelin
- NCT06060587Phase 2Withdrawn
Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone
Gonadorelin
- NCT06247748Phase 1Completed
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
Exenatide
- NCT06085482Phase 1Completed
A Phase I Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05879926Phase 3Recruiting
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Gonadorelin
- NCT06015893Phase 2Recruiting
Semaglutide Therapy for Alcohol Reduction (STAR)
Semaglutide
- NCT06075667Phase 3Active Not Recruiting
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Tirzepatide
- NCT06109649Phase 3Active Not Recruiting
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
Afamelanotide
- NCT05971849Phase 1Completed
Dampening the Reproductive Axis With Continuous Kisspeptin
Kisspeptin
- NCT06001762Phase 2Active Not Recruiting
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
Gonadorelin
- NCT05478707Phase 2Suspended
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Dulaglutide
- NCT05751720Phase 1/Phase 2Unknown
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
Tirzepatide
- NCT06298799N/AUnknown
GENETIC VARIABILITY TO GLP1 TREATMENT
Semaglutide
- NCT07076719N/ACompleted
Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis
Gonadorelin
- NCT03717870N/ANot Yet Recruiting
Surgery and ART For Endometrioma
Gonadorelin
- NCT06097390Phase 1Completed
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
Semaglutide
- NCT06010004Phase 3Completed
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Orforglipron
- NCT06065540Phase 3Completed
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Semaglutide
- NCT05813912Phase 3Completed
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Semaglutide
- NCT06045221Phase 3Completed
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Semaglutide
- NCT06037252Phase 2Active Not Recruiting
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Tirzepatide
- NCT06023095Phase 1Completed
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
Orforglipron
- NCT06047548Phase 3Completed
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Tirzepatide
- NCT06739044Phase 3Completed
Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
Semaglutide
- NCT06024356N/ACompleted
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
Thymosin-Alpha-1
- NCT07309094N/ARecruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Tirzepatide
- NCT06041217Phase 3Completed
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
Semaglutide
- NCT05569772Phase 3Recruiting
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Semaglutide
- NCT06009653Phase 4Withdrawn
Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
Tirzepatide
- NCT06039826Phase 1Completed
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
Retatrutide
- NCT06344247N/AUnknown
Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
Semaglutide
- NCT04972721N/ACompleted
SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
Semaglutide
- NCT06178146Phase 4Unknown
Thymosin Alpha-1 for irAE Secondary to ICIs
Thymosin-Alpha-1
- NCT07374445Phase 4Completed
Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
Liraglutide
- NCT06331286N/AUnknown
The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
Dulaglutide
- NCT06974825Phase 2Completed
A Study of BGM0504 in Chinese Patients With Type 2 Diabetes
Semaglutide
- NCT06003465Phase 1Completed
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
Retatrutide
- NCT05963022Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Tirzepatide
- NCT06143033N/ACompleted
A Clinical Trial to Evaluate the Effects of an Eye Serum on Improving the Appearance of the Periorbital Area
Argireline
- NCT05996848Phase 3Completed
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Semaglutide
- NCT06145308Phase 2Recruiting
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Gonadorelin
- NCT05996874Phase 1Completed
A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants
Semaglutide
- NCT05617885Phase 1Completed
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
Gonadorelin
- NCT05971940Phase 3Completed
A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
Orforglipron
- NCT05984238N/ACompleted
A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2)
Semaglutide
- NCT05931367Phase 3Completed
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
Retatrutide
- NCT05990374N/AUnknown
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
Tirzepatide
- NCT05897372Phase 2Terminated
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Semaglutide
- NCT06025409Phase 3Unknown
Evaluate the Efficacy and Safety of DWJ108J
Gonadorelin
- NCT05978713Phase 1Completed
A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
Tirzepatide